Update From The God Himself - Dr. Takashi Tsuji

J

Joxy

Experienced Member
Reaction score
519
pegasus2 said:
It's hard to say. We know Tsuji will be successful in growing hair, but it's hard to predict what that hair will look like. Worst case scenario it's better than being bald
Click to expand...
Based on the interview that Kondo gave to ’FollicleThought’ guy, they will test 2 hair growth technologies in human trials.

“Regarding the hair regeneration business, we are preparing documents for clinical research, and we plan to transplant regenerated hair follicle primordia into humans as early as the second quarter of 2024. In addition, we are continuing research to further enhance the hair growth rate and plan to sequentially perform primordia transplants into humans using new technology.“

Artificial skin should be a good model for prediction how technology will transfer to humans or?
 
J

Joxy

Experienced Member
Reaction score
519
RolfLeeBuckler

RolfLeeBuckler

Experienced Member
My Regimen
Reaction score
984
pegasus2 said:
It will be the same color. They could use more DP cells to increase the size of each hair shaft beyond your natural density, but the number of DP cells is intrinsically regulated so it would likely return to your natural size with the next hair cycle.
Click to expand...
No, it will be possible to choose the colour by adding Pigment stem cells. It was mentioned by kyocera 2018
 
J

Joxy

Experienced Member
Reaction score
519
OrganTech’s technology like organ primordium is very very powerful technology and theoretically can clone all organs in the body.

en.wikipedia.org

Primordium - Wikipedia

en.wikipedia.org en.wikipedia.org

Dr. Takashi Tsuji mentioned one time in the interview that they choose first to clone hair, teeth and skin, because there are no ethical and safety problems behind those organs, because they grown outside of the body, but their ultimate goal is to clone other organs in the body for transplantation.

Many people ask questions like will be the cloned hair aesthetically normal like the original on your head. There is no reason why not to be, because stem cells have ’memory’ from their previous state and in theory will behave like your original hair after going to hair multiplication/cloning.

www.popularmechanics.com

Scientists Figured Out How to Erase a Cell's Memory and Turn It Into a Stem Cell

Huge.
www.popularmechanics.com www.popularmechanics.com

Btw, from the interview for the FollicleThough guy they mentioned that they will test their new technology in human clinical trials, as well:

-Regarding the hair regeneration business, we are preparing documents for clinical research, and we plan to transplant regenerated hair follicle primordia into humans as early as the second quarter of 2024. In addition, we are continuing research to further enhance the hair growth rate and plan to sequentially perform primordia transplants into humans using new technology.

folliclethought.com

OrganTech Hair Cloning Interview 2023 - Follicle Thought

Follicle Thought is pleased to share an exclusive interview with the CEO of OrganTech as we draw closer to 2024. OrganTech Inc. Resurgence Prior to the year 2020, one researcher’s name was held synonymously with the topic of hair cloning by online hair-seeking communities – Dr. Takashi Tsuji...
folliclethought.com folliclethought.com

If this technology works in practice like they predict, then they can give you full head of hair (norwood 0) that looks aesthetically normal like your previous hair before you went bald, but only human clinical trials will tell us the end results.
 
J

Joxy

Experienced Member
Reaction score
519
OrganTech is entering South Korean market for artificial skin and hair regeneration therapy. Clinical trials should start very soon I guess. Good news.

www.hankyung.com

오건에코텍, 인공장기 재생 분야 진출

오건에코텍, 인공장기 재생 분야 진출, 경제
www.hankyung.com www.hankyung.com

- Takashi Kondo, CEO of Organtech, who attended the signing ceremony on this day, said, “We are confident that the cooperation between the two companies will help our artificial organ regeneration technology grow globally and promote its excellence.”

- Park Jeong-min, CEO of Ogun Ecotech, said, “I am grateful to CEO Takashi for sharing the world’s best artificial organ regeneration technology, and I have become acutely aware that an opportunity has been created for Korean small and medium-sized businesses to grow into global companies.”

- In this contract, Organtech, together with Organ Ecotech, decided to open licenses in the US, Australia and New Zealand so that it can jointly enter the US regenerative medicine field.
 
RolfLeeBuckler

RolfLeeBuckler

Experienced Member
My Regimen
Reaction score
984
Joxy said:
OrganTech is entering South Korean market for artificial skin and hair regeneration therapy. Clinical trials should start very soon I guess. Good news.

www.hankyung.com

오건에코텍, 인공장기 재생 분야 진출

오건에코텍, 인공장기 재생 분야 진출, 경제
www.hankyung.com www.hankyung.com

- Takashi Kondo, CEO of Organtech, who attended the signing ceremony on this day, said, “We are confident that the cooperation between the two companies will help our artificial organ regeneration technology grow globally and promote its excellence.”

- Park Jeong-min, CEO of Ogun Ecotech, said, “I am grateful to CEO Takashi for sharing the world’s best artificial organ regeneration technology, and I have become acutely aware that an opportunity has been created for Korean small and medium-sized businesses to grow into global companies.”

- In this contract, Organtech, together with Organ Ecotech, decided to open licenses in the US, Australia and New Zealand so that it can jointly enter the US regenerative medicine field.
Click to expand...
Thank You for These nice Updates and summarizations!
 
J

Joxy

Experienced Member
Reaction score
519
Question to those guys who are more into deep science.

For example. If OrganTech works in humans and they can clone from 200 hairs up to 20K human hair follicles, so can they take 200 cloned hairs and clone another 20K from them? Is it possible?
 
Marcaronii

Marcaronii

Established Member
My Regimen
Reaction score
521
J

Jakejr

Experienced Member
My Regimen
Reaction score
314
When is this speculation going to offer concrete results to everyday people. Things happening in a laboratory often have little significance unless tested on everyday persons…
 
J

Joxy

Experienced Member
Reaction score
519
OrganTech CEO Takashi Kondo put update on his LinkedIn profile:

“We raised 4.3M US dollars fund through private placement in 2023.OrganTech restarted our business and R&D.In 2024, we made out licensing contracts and collaboration research contracts with some partners.Our revenue is going to reach over 4.6M in this year.We’re also going to conduct clinical research of hair follicles regeneration therapy and bio integration dental implants.Due to successful business development and research progress, we plan to raise further funding to aim for the next stage.Thanks for kindly support to our all partners.“

Check out Takashi Kondo LinkedIn profile:
www.linkedin.com

Takashi Kondo on LinkedIn: We raised 4.3M US dollars fund through private placement in…

We raised 4.3M US dollars fund through private placement in 2023. OrganTech restarted our business and R&D. In 2024, we made out licensing contracts and…
www.linkedin.com www.linkedin.com
 
J

Joxy

Experienced Member
Reaction score
519

Next Era Biotechnology AWARD​


At the WSJ-sponsored "The Future of Everything 2024" Next Era Leaders AWARD ceremony held in New York, our company's Kondo was awarded the "Next Era Biotechnology AWARD" category.

In addition, the award ceremony will be broadcast on Nikkei CNBC's program "New Wave of the Era." A feature article will be published in the national business magazine "Qualitas."

OrganTech’s CEO, Takashi Kondo, on WSJ ceremony.

OrganTech.png


www.organ-tech.jp

弊社近藤が「Next Era Biotechnology AWARD」を受賞しました - 株式会社オーガンテック

弊社近藤がニューヨークにて開催されたWSJ主催の式典にて、「Next Era Biotechnology AWARD」を受賞しました。
www.organ-tech.jp
 
You must log in or register to reply here.
Community platform by XenForo® © 2010-2023 XenForo Ltd.
Top